Dr. Eng is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2220 Pierce Avenue, 777 PRB
Nashville, TN 37232Phone+1 615-322-5000- Is this information wrong?
Summary
- Dr. Cathy Eng is an oncologist in Nashville, TN and is affiliated with Vanderbilt-Ingram Cancer Center. She received her medical degree from Drexel University College of Medicine/Hahnemann University and has been in practice 23 years. She specializes in gastrointestinal cancer clinical research.
Education & Training
- University of ChicagoFellowship, Hematology and Medical Oncology, 1999 - 2002
- Rush University Medical CenterResidency, Internal Medicine, 1996 - 1999
- Rutgers Health/Cooperman Barnabas Medical CenterResidency, Radiology-Diagnostic, 1995 - 1996
- Drexel University College of Medicine/Hahnemann University HospitalInternship, Internal Medicine, 1994 - 1995
- Drexel University College of MedicineClass of 1994
Certifications & Licensure
- TX State Medical License 2002 - 2026
- IL State Medical License 1996 - 2026
- TN State Medical License 2019 - 2025
- AL State Medical License 2020 - 2020
- NJ State Medical License 1995 - 1997
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- White House Cancer Moonshot Colorectal Cancer Panel: Colorectal Cancer Treatment, Innovation and support White House, 2023
- Fellow Hedwig van Ameringen Executive Leadership in Academic Medicine, 2022
- Regional Top Doctor Castle Connolly, 2009-2022
- Join now to see all
Clinical Trials
- Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer Start of enrollment: 2004 Apr 01
- S0408: Capecitabine, Oxaliplatin, and Bevacizumab in Pts Undergoing Surgery for Liver Mets From Colorectal Cancer Start of enrollment: 2006 Nov 01
- Prognostic Molecular and Environmental Factors in High-Risk Colon Cancer Patients Start of enrollment: 2006 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- CLO24-088: Efficacy of Fruquintinib in Less Heavily Pretreated Patients (Pts) With Metastatic Colorectal Cancer (mCRC): Profile-Matched Data From FRESCO and FRESCO-2.Arvind Dasari, Cathy Eng, Sara Lonardi, Rocio Garcia-Carbonero, Toshiki Masuishi, Chiara Cremolini, Francois Ghiringhelli, Joleen Hubbard, Tanios Bekaii-Saab, Jeremy J...> ;Journal of the National Comprehensive Cancer Network. 2024 Apr 5
- Data-driven optimization of version 9 American Joint Committee on Cancer staging system for anal cancer.Lauren M Janczewski, Amanda Browner, Joseph Cotler, Heidi Nelson, Karla V Ballman, Michael LeBlanc, Marc J Gollub, Cathy Eng, James D Brierley, Joel M Palefsky, Richar...> ;Cancer. 2024 May 1
- Mutational Signature Changes in Patients With Metastatic Squamous Cell Carcinoma of the Anal Canal.Christopher Cann, Kristen K Ciombor, Cathy Eng, LaPelusa, M., Michael LaPelusa> ;The Oncologist. 2024 Apr 4
- Join now to see all
Journal Articles
- Spectrum of Somatic Cancer Gene Variations Among Adults with Appendiceal Cancer by Age at Disease OnsetCathy Eng, MD, JAMA Network Open
Press Mentions
- Using an Algorithm to Determine the Right Colon Cancer TreatmentMay 9th, 2023
- Colorectal Cancer in Young PeopleMarch 21st, 2023
- Study Shows Inherited Risk Factors for Appendiceal CancerNovember 11th, 2022
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
- Vanderbilt University Medical CenterNashville, Tennessee
External Links
- LinkedInhttp://www.linkedin.com/in/cathy-eng-18b23b89
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: